Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

AmbiCom Renews and Expands Line of Credit With East West Bank

May 24, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

MILPITAS, Calif., May 24, 2011 /- AmbiCom Holdings, Inc. (OTCQB: ABHI), a leader in the development of wireless products for medical equipment suppliers, today announced that it has signed a new line of credit with East West Bank, renewing and expanding the credit line that was due to...

KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP201 for Pain

May 24, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

NORTH LIBERTY, Iowa, May 24, 2011 /- KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of its most advanced opioid-based drug candidate, KP201, a novel hydrocodone prodrug for treating pain.  KP201 is a new chemical entity (NCE) composed of hydrocodone...

ResMed Announces New iPhone App

May 24, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 24, 2011 /- ResMed (NYSE: RMD ) today released the ResMed Sleep Assessment app, a novel new app for iPhone that lets users record themselves during sleep. The app also includes a clinically validated questionnaire that assesses their risk and other helpful features to...

Advertisement

Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment

May 24, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif. and AUCKLAND, New Zealand, May 24, 2011 /- Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc. (NYSE: VAR ), and Auckland UniServices Ltd. of Auckland, New Zealand, today announced that they have entered into a licensing agreement granting Centella...

Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

May 24, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017...

Reportlinker Adds United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017

May 24, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017...

Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis

May 24, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis...

Boston Heart Lab Changes Name to Boston Heart Diagnostics

May 24, 2011 2:32 am | by Bio-Medicine.Org | News | Comments

FRAMINGHAM, Mass., May 24, 2011 /- Framingham-based Boston Heart Lab announced that it is changing its name to Boston Heart Diagnostics. The company launched its new name and logo at the National Lipid Association Scientific Sessions conference, held May 19-22 in New York City. (Logo:...

Advertisement

Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides

May 24, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Leukemia, Lymphoma and Peptides...

Prometheus Announces Agreement to be Acquired by Nestle Health Science

May 23, 2011 11:32 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 24, 2011 /- Prometheus Laboratories Inc., ("Prometheus") a specialty pharmaceutical and diagnostic company, today announced that it has entered into a definitive agreement to be acquired by Nestle Health Science S.A., a wholly-owned subsidiary of Nestle S.A., for an...

EndyMed Announces the World's First 3DEEP RF Skin Tightening and Fractional Skin Resurfacing Combined Treatment Platform

May 23, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

CAESAREA, Israel, May 23, 2011 /- EndyMed Medical, Ltd., www.endymed.com , a leader in the use of multi-source radiofrequency for professional aesthetic treatments, announced today that the results of a new study will be presented at the upcoming 22nd World Congress of Dermatology, in...

Beckman Coulter, Inc., Synchron LX Clinical Systems Ion Selective Electrolyte (ISE) Flow Cell: Class I Recall - Incorrect Electrolyte Results

May 23, 2011 11:30 am | by U.S. Food & Drug Administration | News | Comments

Errors may be the result of ratio pump wear, silver iodide build-up on the chloride electrode, microbial contamination, and instrument maintenance.

Pentrexyl Forte Natural: Recall - Misleading Packaging

May 23, 2011 10:30 am | by U.S. Food & Drug Administration | News | Comments

Dietary supplement product packaging may cause it to be confused with an antibiotic product.

Advertisement

FDA Schedules Advisory Committee Meeting to Discuss BLA for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration

May 23, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y. May 23, 2011 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today announced that the U.S. Food and Drug Administration (FDA) has informed the company that it has scheduled a Dermatologic and Ophthalmic Drugs Advisory Committee Meeting to be held on June 17, 2011 to...

Heska to Present at SunTrust Robinson Humphrey's Annual Veterinary and Dental Conference

May 23, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

LOVELAND, Colo., May 23, 2011 /- Heska Corporation (NASDAQ: HSKA ) today announced it will present at the SunTrust Robinson Humphrey Annual Veterinary and Dental Conference on Wednesday, June 1, 2011.  The presentation will be at the Le Parker Meridien Hotel at 119 West 56th Street...

Class I Medical Device Recall: Beckman Coulter, Inc., Synchron LX Clinical Systems Ion Selective Electrolyte (ISE) Flow Cell

May 23, 2011 9:30 am | by U.S. Food & Drug Administration | News | Comments

Reason for Recall: There may be ratio pump wear, silver iodide build-up on the chloride electrode, microbial contamination, general non-ISE hardware, and maintenance in the instruments (ion selective electrolyte flow cell) which may cause incorrect...

Use of TIGR® Matrix Surgical Mesh in Multi-Center Randomized Controlled TRAM Flap Study Passes 20 Patient Mark and Wins Praise from Participating Surgeons

May 23, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

SINGAPORE, May 23, 2011 /- Singapore company Novus Scientific Pte. Ltd announced that the TRAM Flap study (Abdominal Wall Closure After Lipectomy, TRAM/DIEP Flap - Comparison of TIGR® (100% Resorbable) vs Polypropylene (Permanent) Mesh) has passed the 20 patient mark, representing...

AACR Calls for Letters of Intent for a Stand Up To Cancer-Melanoma Research Alliance Dream Team

May 23, 2011 8:33 am | by AACR | News | Comments

Tweet PHILADELPHIA - Stand Up To Cancer (SU2C) and the Melanoma Research Alliance (MRA), along with the American Association for Cancer Research, call upon the cancer research community to submit Letters of Intent for a new Dream Team dedicated to melanoma research. The SU2C-MRA Melanoma...

Florida Hospital First U.S. Site to Adopt New Automated Laboratory Solution From Roche

May 23, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla., May 23, 2011 /- Florida Hospital is improving its laboratory testing capabilities with new state-of-the-art equipment from Roche Diagnostics that is designed to help labs increase their testing capacity and deliver reliable results with greater efficiency. The high-volume,...

Siemens Honored by Department of Defense Agency for Supporting Massachusetts Guardsman

May 23, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

NORWOOD, Mass., May, 23, 2011 /- The Norwood, Massachusetts facility of Siemens Healthcare Diagnostics (NYSE: SI ) was honored today with a 'Patriot Award' and an 'Above and Beyond Award' from the Employer Support of the Guard and Reserve (ESGR), a Department of Defense agency. Both...

Ultrafast Laser for Deep Tissue Imaging

May 23, 2011 7:16 am | Spectra-Physics | Product Releases | Comments

Spectra-Physics, a Newport Corporation brand, introduces InSight DeepSee, an extraordinary new ultrafast laser system that takes multiphoton imaging to new depths.

Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement

May 23, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, May 23, 2011 /- Eli Lilly and Company (NYSE: LLY ) today announced that it has signed agreements with private investors Care Capital and NovaQuest Capital to establish BioCritica Inc., a newly-formed and privately-held biotechnology company. BioCritica, based in Central...

Texas Instruments introduces first quad-channel 16-bit, 100 MSPS ADC for faster, smaller medical imaging equipment

May 23, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

DALLAS, May 23, 2011 /- Texas Instruments Incorporated (TI) (NYSE: TXN ) today introduced the first quad-channel, 16-bit analog-to-digital converter (ADC) for medical imaging applications, such as magnetic resonance imaging (MRI). The ADS5263 meets designers' needs for clear, crisp...

CardioGenics to Present at the 7th Annual Spring Growth Stock Conference Hosted by Security Research Associates, Inc.

May 23, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, May 23, 2011 /- CardioGenics Holdings Inc. (CGNH: OTCB) announced today that Dr. Yahia Gawad, CEO of CardioGenics will be presenting at the 7th Annual Spring Growth Stock Conference hosted by Security Research Associates, Inc.  The conference will be held on...

Aethlon Medical to Present the Aethlon ADAPTâ„¢ System at C21 BioVenturesâ„¢ Life Sciences Partnering Conference

May 23, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 23, 2011 / PRNewswire / -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announces that Chairman and CEO James A. Joyce will present the Aethlon ADAPT™ system in a...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading